Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Model-guided microarray implicates the retromer complex in Alzheimer's disease.

Scott A Small1, Kelly Kent, Aimee Pierce

  • 1Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, and the Center for Neurobiology and Behavior, Columbia University College of Physicians and Surgeons, New York, NY, USA. sas68@columbia.edu

Annals of Neurology
|November 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in peritoneal dialysis duration and management among Japanese patients: a nationwide registry analysis.

BMC nephrology·2026
Same author

B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease: a Japan Chronic Kidney Disease Database Extension analysis.

Diabetes research and clinical practice·2026
Same author

Impact of a Transparent Easy Nudge-Based Notification on the Follow-Up Examination Behaviors in Japanese Workers: A Controlled Experiment.

JMA journal·2026
Same author

Clinical Evaluation of the Clinical Reasoning Process of Large Language Models in Nephrology: Comparative Evaluation Study.

JMIR formative research·2026
Same author

Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study.

BMC nephrology·2026
Same author

Effects of canagliflozin on kidney resistive index and oxygenation in patients with type 2 diabetes: findings obtained with ultrasonography and blood oxygenation level-dependent MRI.

Frontiers in clinical diabetes and healthcare·2026
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
Same journal

Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease.

Annals of neurology·2026
Same journal

The Financial Value of an Academic Neurologist.

Annals of neurology·2026
See all related articles

Researchers identified VPS35, a key retromer trafficking molecule, as significantly downregulated in Alzheimer's disease (AD) brains. This finding links retromer dysfunction to the regulation of amyloid-beta peptide levels in AD pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Gene expression profiling faces analytical challenges in brain disorders like Alzheimer's disease (AD).
  • Understanding the spatiotemporal behavior of pathogenic molecules is crucial for AD research.

Purpose of the Study:

  • To develop a spatiotemporal model to predict molecular behavior in AD.
  • To identify and validate novel molecular targets associated with AD pathogenesis.

Main Methods:

  • Construction of a spatiotemporal model for predicting molecular behavior in AD.
  • Gene expression profiling of entorhinal cortex and dentate gyrus from AD and control brains.
  • Western blotting and cell culture studies to validate findings and assess functional relevance.

Related Experiment Videos

Main Results:

  • The retromer trafficking molecule VPS35 best fit the spatiotemporal model for AD.
  • VPS35 levels were reduced in brain regions vulnerable to AD, confirmed by Western blotting.
  • VPS26, another retromer complex member, was also downregulated in AD.
  • VPS35 was shown to regulate amyloid-beta (Abeta) peptide levels in cell culture.

Conclusions:

  • Downregulation of the retromer complex, including VPS35 and VPS26, is implicated in Alzheimer's disease.
  • The retromer complex's dysfunction may contribute to AD pathogenesis by regulating local Abeta peptide levels.